Abiopharma

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

New Form 6-K - ASTRAZENECA PLC Filed: 2025-08-26 AccNo: 0001654954-25-010040 Size: 77 KB

Hemostemix’s Boots on the Ground in Florida

New Form 6-K - SMITH & NEPHEW PLC Filed: 2025-08-26 AccNo: 0001654954-25-010035 Size: 56 KB

New Form 6-K - CYBIN INC. Filed: 2025-08-26 AccNo: 0001833141-25-000012 Size: 58 KB

Dizon Romeo R 🟢 acquired 1.0K shares of IRIDEX CORP (IRIX) at $1.25 Transaction Date: Aug 25, 2025 | Filing ID: 111335

Smith+Nephew PLC Notification

New Form SCHEDULE 13D/A - GeneDx Holdings Corp. Filed: 2025-08-26 AccNo: 0000919574-25-005136 Size: 33 KB

Law Offices of Frank R. Cruz Encourages Nutex Health Inc. (NUTX) Investors To Inquire About Securities Fraud Class Action

SCWorx Expands Healthcare Data Management Network with New Collaboration

New Form 144 - CATALYST PHARMACEUTICALS, INC. Filed: 2025-08-26 AccNo: 0001959173-25-005533 Size: 5 KB

Westlake annuncia lacquisizione dellattività di soluzioni di compounding di ACI

New Form 25 - COSCIENS Biopharma Inc. Filed: 2025-08-26 AccNo: 0001493152-25-012330 Size: 17 KB

Holloway Jean F 🟡 adjusted position in 10.0K shares (1 derivative) of ARTIVION, INC. (AORT) at $44.37 Transaction Date: Aug 25, 2025 | Filing ID: 000005